ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others
13 Décembre 2022 - 1:00PM
Business Wire
ICON finishes the second half of 2022 with an
impressive line-up of awards that commend its healthcare
intelligence work and status as an employer of choice, as
independently judged by industry leaders and peers worldwide.
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence
and clinical research organisation, has been recognised with a
number of coveted business and industry awards over the second half
of 2022 for delivering clinical research services, alongside
specialist collaborations on data, analytics and digital
healthcare.
The awards include the Best Contract Research Organisation –
Full-Service Providers from Scrip, marking the second consecutive
time after a win in 2021. Winners are chosen by an independent
panel of industry experts, each chosen for their knowledge,
objectivity and credibility.
ICON’s innovation capabilities were recognised as the company
won the Data Analytics/Business Intelligence category in the Fierce
Biotech Innovation Awards – Life Sciences 2022. The award was for
ICON’s proprietary One Search tool, which uses intuitive,
integrated workflow and artificial intelligence to provide access
to multiple data sources to help identify optimum trial sites the
first time.
In November, ICON was recognised in the Financial Times European
Leader in Diversity 2023 Award List, ranked 80th out of 850
companies. The list is based on independent surveys of more than
100,000 employees across the continent. They were given the chance
to evaluate their own employer’s diversity and inclusion practices
and to give their perception of those adopted by other prominent
employers in their respective industries. This follows recognition
earlier in the year from Forbes as one of America’s Best Employers
for Diversity for the second year running.
Overall, ICON was named on the 2022 Forbes World’s Best
Employers List, which is based on a survey of 150,000 full-time and
part-time workers from 57 countries.
ICON CEO Steve Cutler commented on the wide range of awards: “We
are pleased to be recognised across the board by industry groups
and leaders as we continue our focus on healthcare intelligence. To
be recognised for innovations that drive clinical research forward,
build an inclusive and diverse workplace and for strong
collaboration with our customers is testament to the tireless
efforts of our talented employees around the globe.”
Additional industry awards and recognition
ICON also won a total of four gold awards at the 2022 MarCom
Awards from the Association of Marketing and Communication
Professionals. ICON’s Creative & Digital Services and Insight
and Evidence & Value teams won a gold award in the Print
Media/Marketing/Promotion/Materials category, while the Creative
& Digital Services and Patient Recruitment Solutions teams won
a gold award in the Digital Media/Web Video/Marketing category.
Additionally, ICON’s Creative & Digital Services and Insights,
Evidence & Value teams won two gold awards in the categories of
Communications/Public Relations/Other – Health Equity-Multicultural
and Marketing/Promotion Campaign/Branding Refresh.
Technology company Medidata awarded ICON a Collaboration of the
Year award for contributions to its RAVE Imaging Platform. This
accolade recognises a unique partnership aimed at delivering a
flexible and high-quality imaging trial experience for sites,
readers and sponsors.
In October, 33 ICON staff members won awards or were finalists
in numerous categories at the PharmaTimes Clinical Researcher of
the Year Americas Awards, including Experienced Contract Research
Associate, Clinical Trial Manager, Global Project Manager,
Start-up—Single, Start-up—Team, Global Project Team, and Global
Partnership Team.
Further success for ICON in the closing months of 2022 came from
wins in the Sales Promotion category and the Poster Design category
at the 2022 Health + Wellness Design Awards hosted by Graphic
Design USA, as well as the Established Irish Investor in Asia Award
from Asia Matters.
A full list of ICON’s industry awards can be viewed at
www.iconplc.com/awards.
About ICON plc
ICON is a world-leading healthcare intelligence and clinical
research organisation. From molecule to medicine, we advance
clinical research providing outsourced development and
commercialisation services to pharmaceutical, biotechnology,
medical device and government and public health organisations. We
develop new innovations, drive emerging therapies forward and
improve patient lives. With headquarters in Dublin, Ireland, ICON
employed approximately 41,150 employees in 113 locations in 53
countries as at September 30, 2022. For further information about
ICON, visit: www.iconplc.com.
ICON/ICLR-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221213005295/en/
Claire Quinn (GMT time zone) Corporate Communications, ICON plc
claire.quinn@iconplc.com +353 87 4066091
Weber Shandwick (PR adviser) Lisa Henry (GMT time zone) +447785
458203 lhenry@webershandwick.com
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
ICON (NASDAQ:ICLR)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024